| Infliximab maintenance therapy for fistulizing Crohn's disease BE Sands, FH Anderson, CN Bernstein, WY Chey, BG Feagan, ... New England Journal of Medicine 350 (9), 876-885, 2004 | 2841 | 2004 |
| Anal-sphincter disruption during vaginal delivery AH Sultan, MA Kamm, CN Hudson, JM Thomas, CI Bartram New England journal of medicine 329 (26), 1905-1911, 1993 | 2095 | 1993 |
| Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine W Kruis, P Frič, J Pokrotnieks, M Lukáš, B Fixa, M Kaščák, MA Kamm, ... Gut 53 (11), 1617-1623, 2004 | 1741 | 2004 |
| Prospective comparison of faecal incontinence grading systems CJ Vaizey, E Carapeti, JA Cahill, MA Kamm Gut 44 (1), 77-80, 1999 | 1547 | 1999 |
| Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis M Rutter, B Saunders, K Wilkinson, S Rumbles, G Schofield, M Kamm, ... Gastroenterology 126 (2), 451-459, 2004 | 1522 | 2004 |
| Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ... The Lancet 389 (10075), 1218-1228, 2017 | 1306 | 2017 |
| Once daily high dose probiotic therapy (VSL# 3) for maintaining remission in recurrent or refractory pouchitis T Mimura, F Rizzello, U Helwig, G Poggioli, S Schreiber, IC Talbot, ... Gut 53 (1), 108-114, 2004 | 1167 | 2004 |
| Mechanisms of action of probiotics: recent advances SC Ng, AL Hart, MA Kamm, AJ Stagg, SC Knight Inflammatory bowel diseases 15 (2), 300-310, 2009 | 1006 | 2009 |
| Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair AH Sultan, MA Kamm, CN Hudson, CI Bartram Bmj 308 (6933), 887-891, 1994 | 941 | 1994 |
| Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study SC Ng, W Tang, JY Ching, M Wong, CM Chow, AJ Hui, TC Wong, ... Gastroenterology 145 (1), 158-165. e2, 2013 | 927 | 2013 |
| Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis MD Rutter, BP Saunders, KH Wilkinson, S Rumbles, G Schofield, ... Gastroenterology 130 (4), 1030-1038, 2006 | 853 | 2006 |
| Myths and misconceptions about chronic constipation SA Müller-Lissner, MA Kamm, C Scarpignato, A Wald Official journal of the American College of Gastroenterology| ACG 100 (1 …, 2005 | 793 | 2005 |
| Characteristics of intestinal dendritic cells in inflammatory bowel diseases AL Hart, HO Al-Hassi, RJ Rigby, SJ Bell, AV Emmanuel, SC Knight, ... Gastroenterology 129 (1), 50-65, 2005 | 770 | 2005 |
| Modulation of human dendritic cell phenotype and function by probiotic bacteria AL Hart, K Lammers, P Brigidi, B Vitali, F Rizzello, P Gionchetti, ... Gut 53 (11), 1602-1609, 2004 | 765 | 2004 |
| Development of the Crohn's disease digestive damage score, the Lémann score B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ... Inflammatory bowel diseases 17 (6), 1415-1422, 2011 | 735 | 2011 |
| A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn’s disease S Schreiber, P Rutgeerts, RN Fedorak, M Khaliq–Kareemi, MA Kamm, ... Gastroenterology 129 (3), 807-818, 2005 | 730 | 2005 |
| Haemorrhoids: pathology, pathophysiology and aetiology PB Loder, MA Kamm, RJ Nicholls, RKS Phillips British journal of surgery 81 (7), 946-954, 1994 | 680 | 1994 |
| Crohn's disease management after intestinal resection: a randomised trial P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ... The Lancet 385 (9976), 1406-1417, 2015 | 663 | 2015 |
| AGA technical review on anorectal testing techniques NE Diamant, MA Kamm, A Wald, WE Whitehead Gastroenterology 116 (3), 735-760, 1999 | 626 | 1999 |
| Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. WR Connell, MA Kamm, JK Ritchie, JE Lennard-Jones Gut 34 (8), 1081-1085, 1993 | 615 | 1993 |
